C-Reactive Protein (CRP) Laboratory Test Overview
CRP is a sensitive acute-phase protein synthesized by the liver in response to inflammation, infection, or tissue injury, serving as one of the most widely requested laboratory tests for assessing systemic inflammation and cardiovascular risk. 1
What CRP Measures
CRP rises rapidly when the body experiences:
- Bacterial or viral infections
- Inflammatory diseases (autoimmune conditions, inflammatory bowel disease)
- Tissue injury or trauma
- Malignancies
- Cardiovascular disease processes
The protein is produced in response to inflammatory cytokines, particularly interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) 1.
Clinical Applications
Infection and Inflammation Monitoring
CRP is extensively used for diagnosing and monitoring inflammatory conditions, including sepsis, trauma, and malignancies 1. However, for sepsis specifically, CRP shows limited diagnostic utility with only 83% sensitivity and 56% specificity, resulting in a concerning 44.3% false-positive rate 2. This high error rate substantially restricts its clinical utility for sepsis diagnosis or prognosis.
Cardiovascular Risk Assessment
For cardiovascular disease risk stratification, the ACC/AHA guidelines cautiously endorse high-sensitivity CRP (hs-CRP) measurement in intermediate-risk individuals, while European guidelines advise against routine use for primary prevention 3, 4. This divergence reflects ongoing uncertainty about CRP's additive value beyond traditional risk factors.
The 2003 CDC/AHA consensus identified CRP as an "emerging risk factor" that could optionally adjust absolute risk estimates obtained through standard risk factors 3. Recent evidence shows that lipid-lowering agents (statins, bempedoic acid) and anti-inflammatory therapies (canakinumab, colchicine) reduce CRP levels and improve cardiovascular outcomes 4.
Interpretation Guidelines
The 10 mg/L Cutoff Controversy
The traditional practice of excluding or flagging CRP values >10 mg/L as indicative of acute infection is outdated and problematic 5. This cutoff originated from a 1981 study using obsolete assay methods in 468 blood donors, where 99% had values <10 mg/L.
Modern evidence reveals:
- In hospitalized patients, 33% with confirmed pathology had CRP <10 mg/L 5
- Among CRP values >10 mg/L, only 40% related to acute respiratory infections, while 20% were associated with smoking behavior 5
- In the current US population (1999-2010), 30-40% exhibit CRP levels >3 mg/L, vastly different from historical distributions 5
Factors Influencing CRP Levels (Beyond Acute Infection)
Multiple non-pathological factors affect CRP concentrations:
- Demographics: Age, sex, race/ethnicity, socioeconomic status
- Lifestyle: Body mass index, exercise, diet, sleep patterns, smoking
- Medications: Various drugs can alter CRP levels
- Genetics: Heritable factors influence baseline CRP 5
Routinely excluding participants or dismissing elevated CRP solely based on the 10 mg/L threshold may inadvertently exclude individuals of clinical interest and reduce the generalizability of findings 5.
Measurement Methods
Standard vs. High-Sensitivity Assays
Traditional CRP tests designed for monitoring acute inflammation lack adequate sensitivity for cardiovascular risk stratification 6. High-sensitivity CRP (hs-CRP) assays were developed to detect lower concentrations relevant for cardiovascular risk assessment.
Common measurement techniques include:
- Immunoturbidimetry (ITM)
- Nephelometry
- Enzyme-linked immunosorbent assay (ELISA)
- Lateral flow immunoassay (LFIA) 7, 8
Both nephelometry and turbidimetry perform comparably, though nephelometry shows slightly lower precision (CV% 3.0-5.8) compared to turbidimetry (CV% 1.8-2.3) in hs-CRP measurement 9.
Analytical Considerations
Preanalytic and analytic variations significantly impact CRP measurement, with implications for cardiovascular risk classification 6. Issues include:
- Lack of complete measurement standardization across assays
- Variability from assay method, kit manufacturer, and operator skill 5
- Fixed cutpoint interpretation requiring careful standardization to avoid risk misclassification 6
Clinical Pitfalls and Recommendations
Common Mistakes to Avoid
Over-reliance on CRP alone: Discrepancies between CRP levels and clinical symptoms are common. CRP should be integrated within a broader diagnostic framework combining patient history, physical examination, and other tests 10.
Habitual testing without clinical reasoning: Reflexive CRP ordering driven by training patterns leads to unnecessary tests and diminished clinical skills 10.
Misinterpreting elevated values: Not all CRP elevations indicate acute infection. Consider chronic inflammatory states, obesity, smoking, and other non-infectious causes 5.
Best Practice Approach
View CRP as one diagnostic tool among many, cultivate a habit of questioning its necessity before ordering, and interpret results in the full clinical context 10. When CRP values exceed 10 mg/L, consider:
- Repeat testing after resolution of potential acute challenges
- Clinical indices of acute phase response
- Patient-specific factors (smoking, obesity, chronic conditions)
- Whether the elevation aligns with clinical presentation 5
The evidence quality for CRP remains moderate, with high heterogeneity across studies and ongoing debates about optimal clinical applications 2, 4.